Add like
Add dislike
Add to saved papers

Doped δ-bismuth oxides to investigate oxygen ion transport as a metric for condensed phase thermite ignition.

Nanothermites offer high energy density and high burn rates, but are mechanistically only now being understood. One question of interest is how initiation occurs and how the ignition temperature is related to microscopic controlling parameters. In this study, we explored the potential role of oxygen ion transport in Bi2 O3 as a controlling mechanism for condensed phase ignition reaction. Seven different doped δ-Bi2 O3 were synthesized by aerosol spray pyrolysis. The ignition temperatures of Al/doped Bi2 O3 , C/doped Bi2 O3 and Ta/doped Bi2 O3 were measured by temperature-jump/time-of-flight mass spectrometer coupled with a high-speed camera respectively. These results were then correlated to the corresponding oxygen ion conductivity (directly proportional to ion diffusivity) for these doped Bi2 O3 measured by impedance spectroscopy. We find that ignition of thermite with doped Bi2 O3 as oxidizer occurs at a critical oxygen ion conductivity (∼0.06 S cm-1 ) of doped Bi2 O3 in the condensed-phase so long as the aluminum is in a molten state. These results suggest that oxygen ion transport limits the condensed state Bi2 O3 oxidized thermite ignition. We also find that the larger oxygen vacancy concentration and the smaller metal-oxide bond energy in doped Bi2 O3 , the lower the ignition temperature. The latter suggests that we can consider the possibility of manipulating microscopic properties within a crystal, to tune the resultant energetic properties.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app